The levels of Th17 cells in the CSF of relapsing MS patients were elevated in comparison to non-inflammatory neurological disease controls, whereas there were no differences in the percentages of IFN-γ-secreting Th1 cells (90). Here, IFNG is linked to myeloid sarcoma.